Mitral annular disjunction in surgical mitral valve prolapse: prevalence, characteristics and outcomes

Rhys Gray; Praveen Indraratna; Gregory Cranney; Hebe Lam; Jennifer Yu; Gita Mathur

doi:10.1186/s44156-023-00032-x

Mitral annular disjunction in surgical mitral valve prolapse: prevalence, characteristics and outcomes

Echo Res Pract. 2023 Nov 8;10(1):21. doi: 10.1186/s44156-023-00032-x.

Authors

Rhys Gray¹, Praveen Indraratna², Gregory Cranney², Hebe Lam³, Jennifer Yu², Gita Mathur²

Affiliations

¹ Department of Cardiology, Prince of Wales Hospital, Sydney, NSW, Australia. rhys_gray@hotmail.com.
² Department of Cardiology, Prince of Wales Hospital, Sydney, NSW, Australia.
³ University of New South Wales, Sydney, Australia.

Abstract

Background: There is a paucity of literature regarding outcomes of patients with mitral valve prolapse (MVP) and mitral annular disjunction (MAD) after mitral surgery, with many unanswered questions including the post-surgical persistence of MAD, effect of MAD on mitral valve reparability, and incidence of arrhythmia after mitral valve surgery. We aimed to examine the prevalence, imaging characteristics and clinical associations of mitral annular disjunction among patients undergoing mitral valve surgery for mitral valve prolapse, as well as outcomes after surgery including the persistence of MAD, arrhythmic events and excess mortality.

Results: A retrospective analysis of 111 consecutive patients who underwent mitral valve surgery for MVP was performed. A total of 32 patients (28.8%) had MAD. Patients with MAD were younger (64 vs 67 yrs, p = 0.04), with lower rates of hypertension (21.9% vs 50.6%, p = 0.01) and hyperlipidaemia (25% vs 50.6%; p = 0.01) and were more likely to be female (43.8% vs 21.4%, p = 0.04) with myxomatous leaflets > 5mm (90.6% vs 15.2%, p = < 0.01) and bileaflet prolapse (31.3% vs 10.1%, p = 0.02). Mitral valve repair was performed in 29/32 patients (90.6%) in the MAD positive group, and no patients had the persistence of MAD post-surgery. Post-operative ventricular arrhythmia was higher in the MAD positive group (28.13% vs 11.69%, p = 0.04) with no difference in mortality, 30-day hospital re-admission, or post-operative mitral regurgitation between patients with and without MAD over 3.91 years of follow up.

Conclusion: In this study of consecutive patients with MVP undergoing surgery, MAD was a common finding (almost 1 in 3). MAD does not compromise mitral valve surgical reparability, and both repair and replacement are effective at correcting disjunction. Our data suggest that concurrent MAD in MVP patients undergoing surgery has no significant effect on post surgical outcomes. Further research as to whether this patient cohort requires post-surgical arrhythmia monitoring is warranted.

Keywords: Mitral; Mitral annular disjunction; Mitral valve prolapse; Mitral valve repair; Valve replacement.